Literature DB >> 12478470

Differential subcellular localization of functionally divergent survivin splice variants.

C Mahotka1, J Liebmann, M Wenzel, C V Suschek, M Schmitt, H E Gabbert, C D Gerharz.   

Abstract

Survivin is an inhibitor of apoptosis protein (IAP) that is markedly overexpressed in most cancers. We identified two novel functionally divergent splice variants, i.e. non-antiapoptotic survivin-2B and antiapoptotic survivin-deltaEx3. Because survivin-2B might be a naturally occurring antagonist of antiapoptotic survivin variants, we analyzed the subcellular distribution of these proteins. PSORT II analysis predicted a preferential cytoplasmic localization of survivin and survivin-2B, but a preferential nuclear localization of survivin-deltaEx3. GFP-tagged survivin variants confirmed the predicted subcellular localization and additionally revealed a cell cycle-dependent nuclear accumulation of survivin-deltaEx3. Moreover, a bipartite nuclear localization signal found exclusively in survivin-deltaEx3 may support cytoplasmic clearance of survivin-deltaEx3. In contrast to the known association between survivin and microtubules or centromeres during mitosis, no corresponding co-localization became evident for survivin-deltaEx3 or survivin-2B. In conclusion, our study provided data on a differential subcellular localization of functionally divergent survivin variants, suggesting that survivin isoforms may perform different functions in distinct subcellular compartments and distinct phases of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12478470     DOI: 10.1038/sj.cdd.4401091

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  50 in total

1.  Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.

Authors:  Pablo E Vivas-Mejia; Cristian Rodriguez-Aguayo; Hee-Dong Han; Mian M K Shahzad; Fatma Valiyeva; Mineko Shibayama; Arturo Chavez-Reyes; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2011-04-21       Impact factor: 12.531

2.  Poriferan survivin exhibits a conserved regulatory role in the interconnected pathways of cell cycle and apoptosis.

Authors:  B Luthringer; S Isbert; W E G Müller; C Zilberberg; N L Thakur; G Wörheide; R H Stauber; M Kelve; M Wiens
Journal:  Cell Death Differ       Date:  2010-07-23       Impact factor: 15.828

3.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

4.  Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.

Authors:  Hugo Caldas; Jason R Fangusaro; Daniel R Boué; Michael P Holloway; Rachel A Altura
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

Review 5.  Survivin study: an update of "what is the next wave"?

Authors:  Fengzhi Li; Xiang Ling
Journal:  J Cell Physiol       Date:  2006-09       Impact factor: 6.384

6.  Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.

Authors:  Salvatore De Maria; Giuseppe Pannone; Pantaleo Bufo; Angela Santoro; Rosario Serpico; Salvatore Metafora; Corrado Rubini; Daniela Pasquali; Silvana M Papagerakis; Stefania Staibano; Gaetano De Rosa; Ernesto Farina; Monica Emanuelli; Andrea Santarelli; Maria Ada Mariggiò; Lucio Lo Russo; Lorenzo Lo Muzio
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-19       Impact factor: 4.553

7.  T-cell responses to survivin in cancer patients undergoing radiation therapy.

Authors:  Dörthe Schaue; Begonya Comin-Anduix; Antoni Ribas; Li Zhang; Lee Goodglick; James W Sayre; Annelies Debucquoy; Karin Haustermans; William H McBride
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

8.  Expression level of wild-type survivin in gastric cancer is an independent predictor of survival.

Authors:  Hua Meng; Cai-De Lu; Yu-Lei Sun; De-Jian Dai; Sang-Wong Lee; Nobuhiko Tanigawa
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

9.  Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo.

Authors:  Robert A Fenstermaker; Sheila A Figel; Jingxin Qiu; Tara A Barone; Sanam S Dharma; Evan K Winograd; Phillip M Galbo; Laura M Wiltsie; Michael J Ciesielski
Journal:  Clin Cancer Res       Date:  2018-03-14       Impact factor: 12.531

10.  Expression of survivin and its four splice variants in colorectal cancer and its clinical significances.

Authors:  Quan-Xing Ge; Yu-Yuan Li; Yu-Qiang Nie; Wen-Ge Zuo; Yan-Lei Du
Journal:  Med Oncol       Date:  2013-03-15       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.